Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lu Si

Showing results (101-110 of 230) with videos related to

Pageof 23
Sort By:
BMC Medicine|January 4, 2023
First-in-human phase I dose-escalation and dose-expansion trial of the selective MEK inhibitor HL-085 in patients with advanced melanoma harboring NRAS mutationsXuan Wang, Zhiguo Luo, Jing Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2013
Large-scale analysis of PDGFRA mutations in melanomas and evaluation of their sensitivity to tyrosine kinase inhibitors imatinib and crenolanibJie Dai, Yan Kong, Lu Si, et al.
World Journal of Urology|April 2, 2025
A prognostic model for survival of patients with metastatic upper tract urothelial carcinoma with first-line systemic therapySiming Li, Jinchang Wei, Huayan Xu, et al.
Zhonghua Yi Xue Za Zhi|December 31, 2014
[Genetic polymorphisms of PDGFR associated with thrombocytopenia in Chinese patients with clear-cell metastatic renal cell carcinoma treated with sunitinib]Xinan Sheng, Yan Kong, Huan Tang, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|January 11, 2025
Genomic characterization reveals distinct mutational landscape of acral melanoma in East AsianFenghao Zhang, Xiaowen Wu, Tao Jiao, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2024
Efficacy and Safety of Postoperative Adjuvant Radiation Therapy in Resected Nasal Cavity and Paranasal Sinus Mucosal Melanoma: A Combined AnalysisBin Lian, Yue Yang, Baomin Zheng, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2019
Identification of a functional polymorphism within the 3'-untranslated region of denticleless E3 ubiquitin protein ligase homolog associated with survival in acral melanomaLu Yang, Jie Dai, Meng Ma, et al.
The British Journal of Ophthalmology|January 18, 2015
Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patientsXinan Sheng, Siming Li, Zhihong Chi, et al.
BMC Medicine|July 2, 2026
Evaluation and analysis of renal injury in patients with advanced renal cell carcinoma receiving first-line benmelstobart plus anlotinib: results from the ETER100 studyJuan Li, Huichun Tian, Huayan Xu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2020
Prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma: A retrospective studyShao-Bo Liang, Lu-Si Chen, Hai-Yang Chen, et al.
Pageof 23

Showing results (101-110 of 230) with videos related to

Sort By:
Pageof 23
BMC Medicine|January 4, 2023
First-in-human phase I dose-escalation and dose-expansion trial of the selective MEK inhibitor HL-085 in patients with advanced melanoma harboring NRAS mutationsXuan Wang, Zhiguo Luo, Jing Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2013
Large-scale analysis of PDGFRA mutations in melanomas and evaluation of their sensitivity to tyrosine kinase inhibitors imatinib and crenolanibJie Dai, Yan Kong, Lu Si, et al.
World Journal of Urology|April 2, 2025
A prognostic model for survival of patients with metastatic upper tract urothelial carcinoma with first-line systemic therapySiming Li, Jinchang Wei, Huayan Xu, et al.
Zhonghua Yi Xue Za Zhi|December 31, 2014
[Genetic polymorphisms of PDGFR associated with thrombocytopenia in Chinese patients with clear-cell metastatic renal cell carcinoma treated with sunitinib]Xinan Sheng, Yan Kong, Huan Tang, et al.
Journal of Genetics and Genomics = Yi Chuan Xue Bao|January 11, 2025
Genomic characterization reveals distinct mutational landscape of acral melanoma in East AsianFenghao Zhang, Xiaowen Wu, Tao Jiao, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2024
Efficacy and Safety of Postoperative Adjuvant Radiation Therapy in Resected Nasal Cavity and Paranasal Sinus Mucosal Melanoma: A Combined AnalysisBin Lian, Yue Yang, Baomin Zheng, et al.
European Journal of Cancer (Oxford, England : 1990)|July 21, 2019
Identification of a functional polymorphism within the 3'-untranslated region of denticleless E3 ubiquitin protein ligase homolog associated with survival in acral melanomaLu Yang, Jie Dai, Meng Ma, et al.
The British Journal of Ophthalmology|January 18, 2015
Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patientsXinan Sheng, Siming Li, Zhihong Chi, et al.
BMC Medicine|July 2, 2026
Evaluation and analysis of renal injury in patients with advanced renal cell carcinoma receiving first-line benmelstobart plus anlotinib: results from the ETER100 studyJuan Li, Huichun Tian, Huayan Xu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 14, 2020
Prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma: A retrospective studyShao-Bo Liang, Lu-Si Chen, Hai-Yang Chen, et al.
Pageof 23